| http://www.w3.org/ns/prov#value | - Preliminary studies show that the nanoparticles are capable of targeting atherosclerotic plaques.The authors have filed a patent for targeted polymeric inflammation-resolving nanoparticles to treat a variety of chronic inflammatory diseases, including atherosclerosis, autoimmune disease, type 2 diabetes, and Alzheimer's disease.The paper is titled, Development and in vivo efficacy of targeted pol
|
